PAPER Chiu HF, Li SW

Alzheimer's disease biomarkers.

Hong Kong Med J. 2012 Aug;18(4):351-2; author reply 352. PubMed: 22865186

PAPER Chow AM, Tang DW, Hanif A, Brown IR

Induction of heat shock proteins in cerebral cortical cultures by celastrol.

Cell Stress Chaperones. 2012 Aug 3; PubMed: 22865541

PAPER Young JE, Goldstein LS

Alzheimer's disease in a dish: promises and challenges of human stem cell models.

Hum Mol Genet. 2012 Oct 15;21(R1):R82-9. PubMed: 22865875

PAPER Dumanis SB, Dibattista AM, Miessau M, Moussa CE, Rebeck GW

APOE genotype affects the pre-synaptic compartment of glutamatergic nerve terminals.

J Neurochem. 2012 Aug 3; PubMed: 22862561

PAPER Martorana A, Di Lorenzo F, Esposito Z, Lo Giudice T, Bernardi G, Caltagirone C, Koch G

Dopamine D(2)-agonist Rotigotine effects on cortical excitability and central cholinergic transmission in Alzheimer's disease patients.

Neuropharmacology. 2013 Jan;64(1):108-13. PubMed: 22863599

PAPER Petersen AJ, Wassarman DA

Drosophila innate immune response pathways moonlight in neurodegeneration.

Fly (Austin). 2012 Jul 1;6(3) PubMed: 22864563

PAPER Kang L, Xiong C, Crane P, Tian L

Linear combinations of biomarkers to improve diagnostic accuracy with three ordinal diagnostic categories.

Stat Med. 2012 Aug 3; PubMed: 22865796

Tiffany Thibaudeau

WVU School of Medicine
Morgantown, United States

PAPER Hohlfeld R, Wekerle H

β-Amyloid: Enemy or Remedy?

Sci Transl Med. 2012 Aug 1;4(145):145fs24. PubMed: 22855459

Salvador Soriano on Aβ’s Good Side—Can It Improve Symptoms of Multiple Sclerosis?

COMMENT Steinman suggests that their results could imply a protective or pathological role for Aβ, depending on the context (i.e., good in MS, bad in AD). However, together with evidence showing an apparent protective role for Aβ in the brain against a variety of

Lei Feng on Cochrane Asks for Field’s Input on Draft Reporting Standards

COMMENT This is an exciting and timely project that will benefit scientific research and clinical practice in the long run. One difficulty I can foresee is that dementia is a long, pathological process rather than an event. So it would be very hard to define a &q

Mick Welling

Principal Investigator
Leiden, Netherlands

Ammar Zakwan

N/A
USJ Subang Jaya, Malaysia

Collaborative Umbrella CAPs Three Prevention Trial Initiatives

CONFERENCE COVERAGE 2012-08-07 Conference Coverage At this year’s Alzheimer’s Association International Conference, 14-19 July 2012, in sunny Vancouver, Canada, some sessions unfolded, somewhat lonesomely, in large, sparsely populated lecture halls. This could not have been more differ

Pei-Jung Lin

Tufts Medical Center
Boston, United States